Zerlasiran showed very significant and durable reductions in lipoprotein(a) of up to 99% Lp(a) levels remained around 90% lower than baseline at study endpoint
November 10, 2023
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to…
Read More
Experts from the Smidt Heart Institute at Cedars-Sinai will present on a variety of topics at AHA 2023. Photo by Cedars-Sinai.
November 10, 2023
Cedars-Sinai Investigators to Unveil New Heart Research at AHA 2023
November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at…
Read More
November 10, 2023
Total Artificial Heart Developer BiVACOR Mechanical Engineer Receives Sezai Innovation Award at ISMCS Annual Conference
November 10, 2023 — BiVACOR, a clinical-stage medical device company developing the Total Artificial Heart (TAH), has…
Read More
Further enhancing comprehensive trauma care solution
November 09, 2023
RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas
November 9, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow…
Read More
Clinical trial data released during VIVA 2023 Conference included results from a study involving the Veryan Medical BioMimics 3D Vascular Stent System.
November 09, 2023
Final Round of Late-breaking Clinical Trial Results Announced at VIVA23
November 9, 2023 — The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular…
Read More
The survey indicates the increased use of RPM to manage care both in clinics and home-based cardiac rehab settings
November 09, 2023
New Cardiac Rehabilitation Survey Reveals 93% of Healthcare Providers Currently Utilize Remote Patient Monitoring Technology
November 9, 2023 — According to a recent survey of healthcare providers (HCPs), 93 percent of clinicians are currently…
Read More
November 09, 2023
Medinbox Debuts New Digital Education Product Suites for Interventional Ecosystem
November 9, 2023 — Medinbox, a global provider of video integrated collaboration systems for interventional rooms and…
Read More
Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise Ultrasound Renal Denervation (RDN) system for the treatment of hypertension.
November 08, 2023
First FDA Approval of Renal Denervation System to Treat Hypertension Announced by Recor Medical and Otsuka Medical Devices
November 8, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. has announced that the…
Read More
Agamon Health's Patient Adherence platform is aimed at raising standards of cardiovascular care
November 08, 2023
Agamon Health enters into know-how agreement with Mayo Clinic to close cardiology care gaps with generative AI
November 8, 2023 — Agamon Health is a healthcare technology company that uses Generative AI and workflow automation to…
Read More
The results come from a national study of more than 1 million U.S. hospital admissions among young adult tobacco users without other known cardiovascular risk factors
November 08, 2023
Prediabetes and Persistent Tobacco Use May Triple Risk of Stroke in Healthy Young Adults
November 8, 2023 — The combination of persistent tobacco use and prediabetes (higher than normal blood sugar levels…
Read More
Nova Heart creates a dynamic, 3D digital twin of a patient’s heart using 2D transthoracic echocardiogram data.
November 08, 2023
AIBODY Introduces Revolutionary Cardiology-centric 3D Digital Twinning Solution
November 8, 2023 — AIBODY, a leader in digital physiology solutions for healthcare, recently announced the release of …
Read More
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
November 07, 2023
Teleflex, and Arrow International, Recall Pressure Injectable Catheter Kits for Mislabeling
November 7, 2023 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and its subsidiary Arrow…
Read More
New add-on code goes into effect Jan. 1, 2024
November 07, 2023
Centers for Medicare and Medicaid Services Establishes New Category I CPT Add-On Code for Coronary IVL
November 7, 2023 — Shockwave Medical, Inc, a pioneer in the development and commercialization of transformational…
Read More
the first patients in the United States have been treated successfully utilizing Abbott’s EnSite X EP System integrated with Stereotaxis’ Robotic Magnetic Navigation System
November 07, 2023
Abbott and Stereotaxis Technologies Used in First Integrated Procedures in the United States
November 7, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular…
Read More
Here's a look at what viewers found most interesting during the month of October on dicardiology.com
By Melinda Taschetta-Millane
November 06, 2023
Top 10: What Viewers Were Reading in October
As another month comes to a close, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.…
Read More
Artificial intelligence (AI) and deep learning models may help to predict the risk of cardiovascular disease events and detect heart valvular disease, according to two preliminary research studies.
November 06, 2023
AI May Accurately Detect Heart Valve Disease and Predict Cardiovascular Risk
November 6, 2023 — Advances in artificial intelligence have enabled the development and application of AI tools that…
Read More
New clinical analyses and real-world data continue to demonstrate the benefit of treatment with CAMZYOS (mavacamten) for patients with symptomatic obstructive HCM
November 06, 2023
Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023
November 6, 2023 —  Bristol Myers Squibb  announced that research across the company’s cardiovascular franchise will be…
Read More
Study suggests CV risk factors and comorbidities could contribute to progression to dementia
November 06, 2023
New Atrial Fibrillation Diagnosis May Increase risk of Memory Decline
November 6, 2023 — Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive…
Read More
Medical University of South Carolina researchers partner with Emergency Medical Services to pilot test the first MRI-equipped ambulance to speed stroke response
November 03, 2023
An MRI-equipped Ambulance: A Game-changer for Stroke Care?
November 3, 2023 — In the U.S., someone has a stroke every 40 seconds and dies from it every three minutes and 14…
Read More
Marlene Rabinovitch, MD, Stanford University
November 03, 2023
Dr. Marlene Rabinovitch to Receive the 2023 AHA Research Achievement Award
November 3, 2023 — The American Heart Association will present its 2023 Research Achievement Award to Marlene…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now